Compugen (CGEN) Earnings Date & Reports

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CGEN is expected to report earnings to -7 cents per share on May 08

Q1'25

Est.

$-0.07

Q4'24

Missed

by $0.09

Q3'24

Beat

by $0.11

Q2'24

Beat

by $0.07

Q1'24

Beat

by $0.03

The last earnings report on March 04 showed earnings per share of -7 cents, missing the estimate of 1 cents. With 152.82K shares outstanding, the current market capitalization sits at 129.40M.

View a ticker or compare two or three

Compare

CGEN